Versatile Structures of α-Synuclein

Bartels, 2011, α-synuclein occurs physiologically as a helically folded tetramer that resists aggregation, Nature, 477, 107, 10.1038/nature10324

Binolfi, 2012, Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?, Biochem. Soc. Trans., 40, 950, 10.1042/bst20120096

Bodner, 2009, Multiple tight phospholipid-binding modes of α-synuclein revealed by solution NMR spectroscopy, J. Mol. Biol., 390, 775, 10.1016/j.jmb.2009.05.066

Bousset, 2013, Structural and functional characterization of two alpha-synuclein strains, Nat. Commun., 4, 2575, 10.1038/ncomms3575

Brunger, 2015, Towards reconstitution of membrane fusion mediated by SNAREs and other synaptic proteins, Crit. Rev. Biochem. Mol. Biol., 50, 231, 10.3109/10409238.2015.1023252

Burré, 2014, α-synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation, Proc. Natl. Acad. Sci. U S A, 111, E4274, 10.1073/pnas.1416598111

Burré, 2010, α-synuclein promotes SNARE-complex assembly in vivo and in vitro, Science, 329, 1663, 10.1126/science.1195227

Burré, 2013, Properties of native brain α-synuclein, Nature, 498, E4, 10.1038/nature12125

Chandra, 2005, Alpha-synuclein cooperates with CSPα in preventing neurodegeneration, Cell, 123, 383, 10.1016/j.cell.2005.09.028

Chartier-Harlin, 2004, Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease, Lancet, 364, 1167, 10.1016/s0140-6736(04)17103-1

Chen, 2015, Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation, Proc. Natl. Acad. Sci. U S A, 112, E1994, 10.1073/pnas.1421204112

Chen, 2007, Investigation of alpha-synuclein fibril structure by site-directed spin labeling, J. Biol. Chem., 282, 24970, 10.1074/jbc.m700368200

Choi, 2013, Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking, Proc. Natl. Acad. Sci. U S A, 110, 4087, 10.1073/pnas.1218424110

Davidson, 1998, Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes, J. Biol. Chem., 273, 9443, 10.1074/jbc.273.16.9443

Dearborn, 2015, α-synuclein amyloid fibrils with two entwined, asymmetrically associated, protofibrils, J. Biol. Chem., 291, 2310, 10.1074/jbc.273.16.9443

Der-Sarkissian, 2003, Structural organization of α-synuclein fibrils studied by site-directed spin labeling, J. Biol. Chem., 278, 37530, 10.1074/jbc.M305266200

Dewitt, 2013, α-synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers, Biochemistry, 52, 2385, 10.1021/bi4002369

Diao, 2013, Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2, Elife, 2, e00592, 10.7554/eLife.00592

Drescher, 2008, Spin-Label EPR on α-synuclein reveals differences in the membrane binding affinity of the two antiparallel helices, Chembiochem, 9, 2411, 10.1002/cbic.200800238

Eliezer, 2001, Conformational properties of α-synuclein in its free and lipid-associated states, J. Mol. Biol., 307, 1061, 10.1006/jmbi.2001.4538

Fauvet, 2012, α-synuclein in central nervous system and from erythrocytes, mammalian cells and Escherichia coli exists predominantly as disordered monomer, J. Biol. Chem., 287, 15345, 10.1074/jbc.M111.318949

Ferese, 2015, Four copies of SNCA responsible for autosomal dominant Parkinson’s disease in two Italian siblings, Parkinsons Dis., 2015, 546462, 10.1155/2015/546462

Ferreon, 2009, Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence, Proc. Natl. Acad. Sci. U S A, 106, 5645, 10.1073/pnas.0809232106

Fusco, 2014, Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour, Nat. Commun., 5, 3827, 10.1038/ncomms4827

George, 1995, Characterization of a novel protein regulated during the critical period for song learning in the zebra finch, Neuron, 15, 361, 10.1016/0896-6273(95)90040-3

Guo, 2013, Distinct α-synuclein strains differentially promote Tau inclusions in neurons, Cell, 154, 103, 10.1016/j.cell.2013.05.057

Gurry, 2013, The dynamic structure of α-synuclein multimers, J. Am. Chem. Soc., 135, 3865, 10.1021/ja310518p

Heise, 2005, Molecular-level secondary structure, polymorphism and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR, Proc. Natl. Acad. Sci. U S A, 102, 15871, 10.1073/pnas.0506109102

Hu, 2016, Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores, Sci. Rep., 6, 20776, 10.1038/srep20776

Iwai, 1995, The precursor protein of non-A beta component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system, Neuron, 14, 467, 10.1016/0896-6273(95)90302-x

Jain, 2013, Structural and dynamical insights into the membrane-bound α-synuclein, PLoS One, 8, e83752, 10.1371/journal.pone.0083752

Jao, 2008, Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement, Proc. Natl. Acad. Sci. U S A, 105, 19666, 10.1073/pnas.0807826105

Karpinar, 2009, Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson’s disease models, EMBO J., 28, 3256, 10.1038/emboj.2009.257

Krüger, 1998, Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease, Nat. Genet., 18, 106, 10.1038/ng0298-106

Lai, 2014, Nonaggregated α-synuclein influences SNARE-dependent vesicle docking via membrane binding, Biochemistry, 53, 3889, 10.1021/bi5002536

Larsen, 2006, α-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis, J. Neurosci., 26, 11915, 10.1523/JNEUROSCI.3821-06.2006

Lashuel, 2002, Neurodegenerative disease: amyloid pores from pathogenic mutations, Nature, 418, 291, 10.1038/418291a

Lashuel, 2013, The many faces of α-synuclein: from structure and toxicity to therapeutic target, Nat. Rev. Neurosci., 14, 38, 10.1038/nrn3406

Lesage, 2013, G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome, Ann. Neurol., 73, 459, 10.1002/ana.23894

Liu, 2012, Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates, Proc. Natl. Acad. Sci. U S A, 109, 20913, 10.1073/pnas.1218792109

Lokappa, 2011, α-synuclein populates both elongated and broken helix states on small unilamellar vesicles, J. Biol. Chem., 286, 21450, 10.1074/jbc.M111.224055

Maroteaux, 1988, Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci., 8, 2804, 10.1523/JNEUROSCI.08-08-02804.1988

Marotta, 2015, O-GlcNAc modification blocks the aggregation and toxicity of the Parkinson’s disease associated protein α-synuclein, Nat. Chem., 7, 913, 10.1038/nchem.2361

Miake, 2002, Biochemical characterization of the core structure of α-synuclein filaments, J. Biol. Chem., 277, 19213, 10.1074/jbc.M110551200

Mizuno, 2012, Remodeling of lipid vesicles into cylindrical micelles by α-synuclein in an extended α-helical conformation, J. Biol. Chem., 287, 29301, 10.1074/jbc.M112.365817

Nemani, 2010, Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis, Neuron, 65, 66, 10.1016/j.neuron.2009.12.023

Paleologou, 2014, Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization and influences synuclein-membrane interactions, J. Neurosci., 30, 3184, 10.1523/JNEUROSCI.5922-09.2010

Pasanen, 2014, A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology, Neurobiol. Aging, 35, 2180.e1, 10.1016/j.neurobiolaging.2014.03.024

Polymeropoulos, 1997, Mutation in the α-synuclein gene identified in families with Parkinson’s disease, Science, 276, 2045, 10.1126/science.276.5321.2045

Proukakis, 2013, A novel α-synuclein missense mutation in Parkinson disease, Neurology, 80, 1062, 10.1212/WNL.0b013e31828727ba

Quist, 2005, Amyloid ion channels: a common structural link for protein-misfolding disease, Proc. Natl. Acad. Sci. U S A, 102, 10427, 10.1073/pnas.0502066102

Rao, 2010, A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins, J. Am. Chem. Soc., 132, 8657, 10.1021/ja100646t

Robotta, 2011, Direct evidence of coexisting horseshoe and extended helix conformations of membrane-bound alpha-synuclein, Chemphyschem, 12, 267, 10.1002/cphc.201000815

Rodriguez, 2015, Structure of the toxic core of α-synuclein from invisible crystals, Nature, 525, 486, 10.1038/nature15368

Segrest, 1990, Amphipathic helix motif: classes and properties, Proteins, 8, 103, 10.1002/prot.340080202

Singleton, 2003, Alpha-synuclein locus triplication causes Parkinson’s disease, Science, 302, 841, 10.1126/science.1090278

Spillantini, 1997, Alpha-synuclein in lewy bodies, Nature, 388, 839, 10.1038/42166

Stroud, 2012, Toxic fibrillar oligomers of amyloid-β have cross-β structure, Proc. Natl. Acad. Sci. U S A, 109, 7717, 10.1073/pnas.1203193109

Theillet, 2016, Structural disorder of monomeric α-synuclein persists in mammalian cells, Nature, 530, 45, 10.1038/nature16531

Tuttle, 2016, Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein, Nat. Struct. Mol. Biol., 23, 409, 10.1038/nsmb.3194

Uéda, 1993, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. U S A, 90, 11282, 10.1073/pnas.90.23.11282

Ulmer, 2005, Structure and dynamics of micelle-bound human α-synuclein, J. Biol. Chem., 280, 9595, 10.1074/jbc.M411805200

Uversky, 2001, Metal-triggered structural transformations, aggregation and fibrillation of human α-synuclein. A possible molecular link between Parkinson’s disease and heavy metal exposure, J. Biol. Chem., 276, 44284, 10.1074/jbc.M105343200

Vilar, 2008, The fold of α-synuclein fibrils, Proc. Natl. Acad. Sci. U S A, 105, 8637, 10.1073/pnas.0712179105

Wang, 2014, Alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling, Curr. Biol., 24, 2319, 10.1016/j.cub.2014.08.027

Weinreb, 1996, NACP, a protein implicated in Alzheimer’s disease and learning, is natively unfolded, Biochemistry, 35, 13709, 10.1021/bi961799n

Winner, 2011, In vivo demonstration that α-synuclein oligomers are toxic, Proc. Natl. Acad. Sci. U S A, 108, 4194, 10.1073/pnas.1100976108

Zarranz, 2004, The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol., 55, 164, 10.1002/ana.10795